Teleflex Secures FDA 510(k) Clearance for Broader Use of QuikClot Control+™ Hemostatic Device
On April 30, 2025, Teleflex Incorporated, a global leader in medical technologies, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded Indications for Use of its QuikClot Control+™ Hemostatic Device. The clearance extended the device’s application to include all grades of internal and external bleeding. Previously, the QuikClot Control+™ Device was cleared for the temporary control of class III and IV internal organ space bleeding, severely bleeding surgical wounds, mild to moderate bleeding in cardiac procedu...
